NucleoBio Corp
PrivateLast Round
Accelerator
Jun 1, 2017
Total Funding Raised
$25,000
Momentum
Top 50%
of companies Caplight tracks
Company Overview
NucleoBio Corp is a biotechnology company that develops RNA-based assays and molecular diagnostics for precision oncology derived from peer-reviewed research.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Medical AI, Healthcare Analytics
Business Model
B2B
Customer Profile
Usage-Based SaaS, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NucleoBio Corp Comparables
Compare NucleoBio Corp with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| MiRNA Scientific | 87% | |
| Minomic International | 85% | |
| LynxDx | 85% |
NucleoBio Corp Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Jun 1, 2017 |
Key People
Founding team and executive leadership
NucleoBio Corp Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Science Foundation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 20, 2026
Monthly visitors increased 480% MoM, reaching 2K.
NucleoBio Corp Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about NucleoBio Corp's valuation, stock price, and market status.
Is NucleoBio Corp a public or private company?
NucleoBio Corp is a private company.
What is the current stock price of NucleoBio Corp?
NucleoBio Corp is a private company, so its shares have no public market price. Caplight tracks NucleoBio Corp's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is NucleoBio Corp worth (valuation)?
Valuation information for NucleoBio Corp is not publicly available.
Can I buy NucleoBio Corp stock?
NucleoBio Corp shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was NucleoBio Corp's last funding round?
NucleoBio Corp's most recent funding round was Accelerator on June 1, 2017.
Who are the main investors in NucleoBio Corp?
Key investors in NucleoBio Corp include National Science Foundation.
Will NucleoBio Corp IPO soon?
No public IPO plans have been announced for NucleoBio Corp.
How can I track NucleoBio Corp secondary market activity?
Caplight tracks bids, offers, and trades in NucleoBio Corp's shares on secondary markets.